Which pharmaceutical company first launched a nationwide insulin subscription model that capped monthly patient costs regardless of insurance status?

The healthcare industry has seen significant changes in how medications are delivered to patients. Subscription models have transformed patient access to critical medications, especially for chronic conditions. This poll explores a groundbreaking medication subscription service that changed how patients receive their prescriptions. Test your knowledge about innovative business models in the pharmaceutical space!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Eli Lilly with 'Lilly Insulin Value Program'
Novo Nordisk with 'NovoCare Subscription'
Sanofi with 'Insulins ValYOU Savings Program'
Biocon with 'Insulin For All Monthly'